Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007
about
Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infectionsEstimating the Number of Heterosexual Persons in the United States to Calculate National Rates of HIV InfectionAgent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C InfectionsMonitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for preventionEstimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.Toward a more accurate estimate of the prevalence of hepatitis C in the United States.Factors associated with initiating someone into illicit drug injection.The entry of Colombian-sourced heroin into the US market: the relationship between competition, price, and purity.Tailored combination prevention packages and PrEP for young key populations.Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.Female and male differences in AIDS diagnosis rates among people who inject drugs in large U.S. metro areas from 1993 to 2007.Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan ChicagoBiomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions.Population Size Estimates for Men who Have Sex with Men and Persons who Inject DrugsThe influence of a peer-based HIV prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, MarylandAn international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.The role of social networks and geography on risky injection behaviors of young persons who inject drugs.Epidemiology of Injection Drug Use: New Trends and Prominent Issues.Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009Factors associated with being asked to initiate someone into injection drug useAssociation between prescription drug misuse and injection among runaway and homeless youth."It's Not What You Know but Who You Know": Role of Social Capital in Predicting Risky Injection Drug Use Behavior in a Sample of People who Inject Drugs in Baltimore City.Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals?Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of researchPersistent racial/ethnic disparities in AIDS diagnosis rates among people who inject drugs in U.S. metropolitan areas, 1993-2007.The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study.Projected demographic composition of the United States population of people living with diagnosed HIV.Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States.High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members.Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California.Gender, Transience, Network Partnerships and Risky Sexual Practices Among Young Persons who Inject Drugs.HIV infection and HIV-associated behaviors among persons who inject drugs--20 cities, United States, 2012.Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in medicare patients.The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings.Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009.HIV and adolescents: focus on young key populations.HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 20 Cities, United States, 2015.Iris abscess a rare presentation of intravenous drug abuse associated Candida endophthalmitis.Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
P2860
Q28538968-385CB82D-6F2D-4E3D-832B-0B1D5623C4B2Q28546801-69CBEAE1-FE81-43D8-BA38-65948BE114B9Q28548643-BFA4E000-02F6-4851-AC4E-D4469F823CEAQ33592665-402DE075-835D-4529-BC53-805B2BA7C78FQ33707925-1F8EDDEE-3AA5-4118-B796-205B2844A357Q33724701-41A6FAD2-F48B-4E2C-9ABC-D306E0DEB6CBQ34484872-AC209188-5B11-4B0D-BC29-B5DDFA842C67Q34773972-A4B25917-ACE2-4713-90B6-63EDFB32EF66Q35037760-BA4FCA6B-857F-4519-91CE-53D3903AD9A3Q35131207-C0599F9B-4BFE-4235-9402-E8D1192A5265Q35581138-9CB296FE-505B-48E6-89BE-399CED67A82FQ35751758-6C0A0DF8-1DF6-492D-B7E8-18C59095EB08Q35752296-D412AEB3-DBC5-4EC5-9670-86D22C47B837Q35817533-4303769B-8A09-4F62-A09C-CFA442A8A9C6Q35916024-B8BA2A9E-20B9-4550-A387-F9B3B12627A9Q36052814-6C6C0E80-3C42-4037-8402-BADBFCE13BA3Q36090175-4A4CB428-469D-4397-998F-85EB7970EA1BQ36701887-F2074B9B-51B4-46C8-A0A4-9F5E732CF512Q36744335-C20D7CF7-62F1-40C5-8828-4E7F37141166Q37040594-CEEB3008-6B5E-43F9-948E-E45325DD92C2Q37308020-4BC5E5FD-60B2-4F9F-ADC7-CB7C2F7F1085Q37455559-7B02573A-9279-465D-AC02-852C394A7108Q37613588-BCD739BB-F6A1-46AA-9BEF-343BA016FE3FQ37638230-BC4AB5CD-3B8A-49AF-816D-A19927E32FDCQ37691641-06F41C67-CB2E-412B-B2FA-2A0FA5B096FBQ37696114-4A646AA4-BB1D-4DCF-9A15-5AD7288E0440Q38652562-253C3A97-81D0-4A8B-B07C-304BE71910C4Q38844009-DEAD5B13-9FB2-4D3D-9AF6-EC3D927F69F6Q39825094-18AA99DF-164F-4276-8554-1D85FC0E6F3EQ40056569-807F10ED-35CE-40AD-9481-A0C276B0CA7FQ40464430-A7CC8B89-9EA5-4B8B-92C1-C4A51EE17F0CQ40537570-D7CD74C7-805E-451A-A418-BFB3B7474987Q41193569-01890043-6350-4DEB-A5C3-F0E714A57DC7Q41261310-56F2C437-FAFF-452C-AA9A-71D20C528E83Q41919051-ECDD12BB-FDF3-4833-9932-2191F530B36FQ42208893-E8BC113F-E3E3-4507-B6DF-82D5255D6C37Q46119171-66326066-8F69-4776-BD44-BA1B1764219CQ47555256-C42658B9-C0B2-4566-B335-DF6B62ED8950Q50334319-293C1C31-C4F1-4A88-A9AD-82A80E8E0EA8Q52622035-78ED4054-3900-4DB6-884F-E3EF629609D7
P2860
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Trends in the population preva ...... S metropolitan areas 1992-2007
@ast
Trends in the population preva ...... S metropolitan areas 1992-2007
@en
Trends in the population preva ...... S metropolitan areas 1992-2007
@nl
type
label
Trends in the population preva ...... S metropolitan areas 1992-2007
@ast
Trends in the population preva ...... S metropolitan areas 1992-2007
@en
Trends in the population preva ...... S metropolitan areas 1992-2007
@nl
prefLabel
Trends in the population preva ...... S metropolitan areas 1992-2007
@ast
Trends in the population preva ...... S metropolitan areas 1992-2007
@en
Trends in the population preva ...... S metropolitan areas 1992-2007
@nl
P2093
P2860
P1433
P1476
Trends in the population preva ...... S metropolitan areas 1992-2007
@en
P2093
Amy Lansky
Brooke S West
Charles M Cleland
Enrique R Pouget
H Irene Hall
Hannah L F Cooper
Joanne E Brady
Samuel R Friedman
P2860
P304
P356
10.1371/JOURNAL.PONE.0064789
P407
P577
2013-01-01T00:00:00Z